Clinical evaluation of extra-hematologic comorbidity in myelodysplastic syndromes: ready-to-wear versus made-to-measure tool

Ítems similars

• Risk stratification based on both disease status and extra-hematologic comorbidities in patients with myelodysplastic syndrome
  per: Della Porta, Matteo G., et al.
  Publicat: (2011)
• Clinical relevance of extra-hematologic comorbidity in the management of patients with myelodysplastic syndrome
  per: Porta, Matteo Giovanni Della, et al.
  Publicat: (2009)
• Impact of the degree of anemia on the outcome of patients with myelodysplastic syndrome and its integration into the WHO classification-based Prognostic Scoring System (WPSS)
  per: Malcovati, Luca, et al.
  Publicat: (2011)
• Inappropriately low hepcidin levels in patients with myelodysplastic syndrome carrying a somatic mutation of SF3B1
  per: Ambaglio, Ilaria, et al.
  Publicat: (2013)
• Myelodysplastic syndromes with bone marrow fibrosis
  per: Della Porta, Matteo Giovanni, et al.
  Publicat: (2011)